View drug registration information details.


ItemsRegistration information
ID369
No369
Brand NameV-GAVIR 450
IngredientsVALGANCICLOVIR HCL USP EQ.TO VALGANCICLOVIR 450 MG
Dosage FormFILM-COATED TABLETS
Primary PackagingALU-STRIP
StorageSTORE AT 25 C, PROTECT FROM MOISTURE
Shelf Life2 YEARS
Pack SizeBOX OF 5 X 4'S
Dispensing CategoryPrescription only
ATC ClassificationJ05AB14
Pharmaceutical ClassANTIVIRAL
IndicationsFOR THE INDUCTION AND MAINTENANCE TREATMENT OF CYTOMEGALOVIRUS RETINITIS IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME, FOR THE PREVENTION OF CMV DISEASE IN CMV-NEGATIVE PATIENTS WHO HAVE RECEIVED A SOLID ORGAN TRANSPLANT FROM A CMV-POSITIVE DONOR
ContraindicationsHYPERSENSITIVITY, IN PATIENTS WITH HYPERSENSITIVITY TO ACICLOVIR AND VALACICLOVIR, DURING BREAST-FEEDING
Side EffectsNEUTROPENIA, ANEMIA, DIARRHEA,
Unit Price15.2
EDL No
DescriptionDARK BROWN COLOURED, CAPSULE SHAPED BICONVEX, FILM COATED TABLETS
Note
License OwnerCBF PHARMA CO.,LTD
ManufacturerUNITED BIOTECH (P) LIMITED
CountryINDIA
Import Registration NoMNB/05/254
Import Registration Date2016-02-23
ActivityCERTIFICATE RELEASED
Applied Date2023-05-05
FDD Registration No06 I 4943/20
FDD Registration Date2023-08-14
Expiry Date2026-08-13

Back to drug list